MenoBrain Brain Health in Menopausal Women
- Coordinator
- Universitatsklinikum Jena, Germany
- Runs
- 1 September 2025 to 31 August 2029
- Status
- Running
- EU funding
- €4.5m
- Total cost
- —
- Partners
- 20 organisations in 10 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101227102
What the project is doing
In the project's own words, from its summary on CORDIS.
With the global population of menopausal women projected to reach 1.2 billion by 2030, menopause represents a critical yet understudied period in women's health. Hormonal changes during this transition pose significant risks to brain health, cognitive function, and emotional well-being, while increasing vulnerability to age-related diseases such as Alzheimer's disease. Despite its profound societal relevance, menopause-related brain changes remain poorly understood, with limited biomarkers and evidence-based interventions available.
MenoBrain aims to fill this gap by training a new generation of 15 doctoral candidates to address the pressing challenges of menopause-related brain health. The DCs will work within a multidisciplinary and international network of 18 participants (11 beneficiaries and 7 partners) spanning neuroimaging, neuropsychology, endocrinology, microbiome research and bioinformatics. MenoBrain will employ cutting-edge methods including advanced neuroimaging (MRI, DTI, PET, EEG), host-microbiome modelling, and computational BrainAGE models.
This integrated approach will explore how hormonal changes associated with menopause and interventions such as menopausal hormone therapy impact cognitive health, gut-brain communication, and aging trajectories. The programme combines scientific excellence with a robust training structure to equip MenoBrain doctoral candidates with expertise in interdisciplinary and intersectoral research, advanced technologies, and transferable skills.
By leveraging state-of-the-art infrastructure, MenoBrain will discover biomarkers for early detection of cognitive dysfunction, improve therapeutic strategies, and advance personalized healthcare for menopausal women. MenoBrain not only addresses a critical gap in women's health research, but also aligns with the EU's agenda to promote healthy aging, gender-specific healthcare, and fostering innovative training for the next generation of leaders in science and industry.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitatsklinikum Jena | Jena | Germany | Coordinator |
| Paris-Lodron-Universitat Salzburg | Salzburg | Austria | Participant |
| Christian-Albrechts-Universitaet Zu Kiel | Kiel | Germany | Associatedpartner |
| Eberhard Karls Universitaet Tuebingen | Tuebingen | Germany | Participant |
| Kerstin Minnich | Wolfratshausen | Germany | Associatedpartner |
| Medice Arzneimittel Pütter GmbH & Co. KG | Iserlohn | Germany | Associatedpartner |
| Synaptikon GmbH | Berlin | Germany | Associatedpartner |
| Universitatsklinikum Schleswig-Holstein | Lübeck | Germany | Participant |
| Fundacio Barcelonabeta Brain Research Center | Barcelona | Spain | Participant |
| Universidad Pompeu Fabra | Barcelona | Spain | Associatedpartner |
| Finnadvance Oy | Helsinki | Finland | Participant |
| Institut National De La Sante Et De La Recherche Medicale | Paris | France | Participant |
| Universite De Lorraine | Nancy Cedex | France | Associatedpartner |
| Vilniaus Universitetas | Vilnius | Lithuania | Participant |
| Alzheimer Europe | Senningerberg | Luxembourg | Associatedpartner |
| Bastiaanse Communication B.V. | Bosch En Duin | Netherlands | Associatedpartner |
| Science Matters | Vlaardingen | Netherlands | Associatedpartner |
| Universiteit Leiden | Leiden | Netherlands | Participant |
| Diakonhjemmet Sykehus AS | Oslo | Norway | Participant |
| Uppsala Universitet | Uppsala | Sweden | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI